• The AI platform landscape:
-Biology-first vs chemistry-driven vs lab-integrated approaches
-Where differentiation is real & where it is overstated
• Where AI is delivering value today
• How pharma is engaging with AI platforms in practice
• Scalability, integration, and long-term ROI
Moderator: Alex Ide, General Manager, Genomics Genomics
Panellists:
Kelly Gray, Senior Alliances Manager, Ignota Labs
Yann Gaston-Mathé, Chief Executive Officer, Iktos AI
Dave Hallett, Chief Scientific Officer, Recursion
Peyman Gifani, Chief Executive Officer & Founder, AI VIVO
